Recombinant activated factor VII is associated with postoperative thromboembolic adverse events in bleeding after coronary surgery

Interactive Cardiovascular and Thoracic Surgery

Volumn 27, Issue 3, 2018, Pages 350-356

  Habib, Aly Makram ^a,b,c   Calafiore, Antonio Maria ^d   Cargoni, Marco ^e   Foschi, Massimiliano ^e   Di Mauro, Michele ^f  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b PRINCE SULTAN CARDIAC CENTER   (Saudi Arabia)

^c CAIRO UNIVERSITY   (Egypt)

^d Department of Cardiac Surgery   (Italy)

^e Policlinico SS Annunziata   (Italy)

^f IEMA Istituto Europeo Medicina della Riproduzione Abruzzese   (Italy)

Author keywords

Coronary artery bypass grafting; Post surgical bleeding; Recombinant activated factor VII; Retrospective analysis; Thromboembolic adverse events

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; BLOOD CLOTTING FACTOR 7A; COAGULATING AGENT; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ADULT; ARTERY THROMBOSIS; ARTICLE; BLOOD EXAMINATION; CARDIAC SURGERY INTENSIVE CARE UNIT; CEREBROVASCULAR ACCIDENT; COLOR DOPPLER ECHOCARDIOGRAPHY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; EUROSCORE; FEMALE; HEART INFARCTION; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; INTRAOPERATIVE PERIOD; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSTHORACIC ECHOCARDIOGRAPHY; AGED; INCIDENCE; MIDDLE AGED; THROMBOEMBOLISM;

AGED; COAGULANTS; CORONARY ARTERY BYPASS; FACTOR VIIA; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; THROMBOEMBOLISM;

EID: 85055633790     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivy067     Document Type: Article

References (29)

1. Boyle EM, Verrier ED, Spiess BD. The procoagulant response to injury. Ann Thorac Surg 1997;64:S16–23.
2. Karthik S, Grayson AD, McCarron EE, Pullan DM, Desmond MJ. Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay. Ann Thorac Surg 2004;78: 527–34.
3. Dacey LJ, Munoz JJ, Baribeau YR, Johnson ER, Lahey SJ, Leavitt BJ. Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group. Arch Surg 1998;133:442–7.
4. Hedner U, Erhardtsen E. Potential role for rFVIIa in transfusion medicine. Transfusion 2002;42:114–24.
5. Al Douri M, Shafi T, Al Khudairi D, Al Bokhari E, Black L, Akinwale N. Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coagul Fibrinolysis 2000;11:S121–S7.
6. von Heymann C, Hotz H, Konertz W, Kox WJ, Spies C. Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2002;16: 615–6.
7. Willis C, Bird R, Mullany D, Cameron P, Phillips L. Use of rFVIIa for critical bleeding in cardiac surgery: dose variation and patient outcomes. Vox Sang 2010;98:531–7.
8. Hardy JF, Belisle S, Van der Linden P. Efficacy and safety of activated recombinant factor VII in cardiac surgical patients. Curr Opin Anaesthesiol 2009;22:95–9.
9. Davies MJ. The pathophysiology of acute coronary syndromes. Heart 2000;83:361–6.
10. Ernofsson M, Thelin S, Siegbahn A. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study. J Thorac Cardiovasc Surg 1997;113:576–84.
11. Khan MM, Hattori T, Niewiarowski S, Edmunds LH Jr, Colman RW. Truncated and microparticle-free soluble tissue factor bound to peripheral monocytes preferentially activate factor VII. Thromb Haemost 2006; 95:462–8.
12. Pichon N, Bellec F, Sekkal S, Marsaud JP, Laskar M, Francois B et al. Fatal thrombotic event after infusion of recombinant activated factor VII after cardiac surgery. J Thorac Cardiovasc Surg 2008;136:220–1.
13. Kouchoukos NT, Blackstone EH, Hanley FL, Kirklin JK. Kirklin/Barrett-Boyes Cardiac Surgery: Expert Consult, 4th edn. Philadelphia: Elsevier Saunders, 2013.
14. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR et al. EuroSCORE II. Eur J Cardiothorac Surg 2012;41:734–45.
15. Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A et al. An updated definition of stroke for the 21st century. A statement for healthcare professionals from the American Heart Association/American Stroke Association. On behalf of the American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, Council on Peripheral Vascular Disease, and Council on Nutrition, Physical Activity and Metabolism. Stroke 2013;44:2064–89.
16. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Circulation 2012;126:2020–35.
17. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N et al. Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2014;35:3033–73.
18. Levi M, Peters M, Büller HR. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. Crit Care Med 2005;33:883–90.
19. Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010;363:1791–800.
20. Habib AM, Mousa AY, Al-Halees Z. Recombinant activated factor VII for uncontrolled bleeding post cardiac surgery. J Saudi Heart Assoc 2016;28: 222–31.
21. Habib AM. Comparison of low and high dose recombinant activated factor VII for postcardiac surgical bleeding. Indian J Crit Care Med 2016; 20:497–503.
22. Mayer SA. Recombinant activated factor VII for acute intracerebral hemorrhage. Stroke 2007;38:763–7.
23. Ponschab M, Landoni G, Biondi-Zoccai G, Bignami E, Frati E, Nicolotti D et al. Recombinant activated factor VII increases stroke in cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 2011;25:804–10.
24. Biancari F, Ruggieri VG, Perrotti A, Svenarud P, Dalén M, Onorati F et al. European Multicenter Study on Coronary Artery Bypass Grafting (E-CABG registry): study protocol for a prospective clinical registry and proposal of classification of postoperative complications. J Cardiothorac Surg 2015;10:90.
25. Zangrillo A, Mizzi A, Biondi-Zoccai G, Bignami E, Calabrò MG, Pappalardo F et al. Recombinant activated factor VII in cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 2009;23:34–40.
26. Diprose P, Herbertson MJ, O’Shaughnessy D, Gill RS. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. Br J Anaesth 2005;95:596–602.
27. Biancari F, Mikkola R, Heikkinen J, Lahtinen J, Airaksinen KE, Juvonen T. Estimating the risk of complications related to reexploration for bleeding after adult cardiac surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg 2012;41:50–5.
28. Ranucci M. Outcome measures and quality markers for perioperative blood loss and transfusion in cardiac surgery. Can J Anesth 2016;63: 169–75.
29. Chapman AJ, Blount AL, Davis AT, Hooker RL. Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery. Eur J Cardiothorac Surg 2011;40:1314–9.